Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. EPS 2020–2025
Fulcrum Therapeutics Inc. annual/quarterly eps history and growth rate from 2020 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Fulcrum Therapeutics Inc. eps for the quarter ending September 30, 2025 was $0.31, a 11.43% decrease year-over-year.
- Fulcrum Therapeutics Inc. annual eps for 2025 was $1.18, a 637.50% increase from 2024.
- Fulcrum Therapeutics Inc. annual eps for 2024 was $0.16, a 89.94% decrease from 2023.
- Fulcrum Therapeutics Inc. annual eps for 2023 was $1.59, a 34.84% decrease from 2022.
- Fulcrum Therapeutics Inc. annual eps for 2022 was $2.44.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Fulcrum Therapeutics Inc. EPS — FAQ
Fulcrum Therapeutics Inc. (FULC) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Fulcrum Therapeutics Inc.'s eps?
Fulcrum Therapeutics Inc. (FULC) reported eps of $-1.18 for fiscal 2025.
Where can I see FULC's eps history?
The chart and table above show Fulcrum Therapeutics Inc.'s eps by year and by quarter, including the growth rate.